These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30005851)

  • 21. lncRNA and mRNA signature for prognosis prediction of glioblastoma.
    Liu G; Pan Y; Li Y; Xu H
    Future Oncol; 2020 May; 16(13):837-848. PubMed ID: 32250161
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.
    Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X
    Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
    Zhang X; Jiang Y; Xie Y; Leng X; Song F
    DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of N
    Wang W; Li J; Lin F; Guo J; Zhao J
    Neurosurg Rev; 2021 Feb; 44(1):463-470. PubMed ID: 31938968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Bioinformatics Analysis Reveals Potential Long Non-Coding RNA Biomarkers and Analysis of Function in Non-Smoking Females with Lung Cancer.
    Qiao F; Li N; Li W
    Med Sci Monit; 2018 Aug; 24():5771-5778. PubMed ID: 30120911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
    Yang S; Xu J; Zeng X
    Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
    Hu C; Zhou Y; Liu C; Kang Y
    Oncol Rep; 2018 Nov; 40(5):2467-2476. PubMed ID: 30106138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Analysis of a Hypoxia-Associated lncRNA Signature in Glioblastoma and its Pan-Cancer Landscape.
    Qin Y; Zhang X; Chen Y; Zhang W; Du S; Ren C
    J Neurol Surg A Cent Eur Neurosurg; 2024 Jul; 85(4):378-388. PubMed ID: 37023792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNAs in glioma progression.
    Xi J; Sun Q; Ma L; Kang J
    Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
    Li D; Lu J; Li H; Qi S; Yu L
    Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles.
    Liu Q; Qi C; Li G; Su W
    Biomed Res Int; 2019; 2019():5076467. PubMed ID: 31950039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.